The Pistoia Alliance is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing ...

November 29, 2022 Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator Clinigen Limited (‘Clinigen’ or the ‘Company’), the global pharmaceutical services ...

EVERSANA has launched a new pharmacovigilance (PV) platform that answers the need to apply advanced data analytics and ...

In this episode presented by IQVIA, BioSpace's head of insights Lori Ellis discusses the evolving role of local qualified ...

The rebranding follows the company’s integration into the Fishawack group of companies, a global specialist in medical communications services. Founded in 1997 in Zofingen, Switzerland, Fishawack ...

Robert leads Oracle’s Safety customer engagement programs, including the Safety Consortium and strategic Lighthouse Customer programs. Through these programs, Oracle strives to collaborate with ...

Reven Selects Its Service Provider in Pharmacovigilance, Safety Monitoring, QA, and Regulatory Affairs for Its Upcoming COVID-19 Clinical Trial ...

As you can read in our full report, “Unlocking the Power of Pharmacovigilance: An Adaptive Approach to an Evolving Drug Safety Environment,” we suggest that firms can address challenges to ...

Pharmacovigilance is relates to the detection, assessment, understanding, and prevention of adverse effects or any drug-related problem for patient safety. Post-marketing drug surveillance ...

Useful links Further event detailsMore information about the event Speakers GIOVANNI FURLAN Safety Risk Lead - Director Pfizer, Italy MATE A. BALAZS Country Head - Patient Safety Novartis, Hungary ...